Cargando…

The effects of tumor resection and adjuvant therapy on the peripheral blood immune cell profile in patients with colon carcinoma

OBJECTIVE: The subset distribution and immunophenotype of circulating immune cells (“peripheral blood immune cell profile”) may reflect tumor development and response to cancer treatment. In order to use the peripheral blood immune cell profile as biomarker to monitor patients over time, it is cruci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krijgsman, Daniëlle, De Vries, Natasja L., Andersen, Morten N., Skovbo, Anni, Tollenaar, Rob A. E. M., Bastiaannet, Esther, Kuppen, Peter J. K., Hokland, Marianne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511291/ https://www.ncbi.nlm.nih.gov/pubmed/32399587 http://dx.doi.org/10.1007/s00262-020-02590-z

Ejemplares similares

CD163 as a Biomarker in Colorectal Cancer: The Expression on Circulating Monocytes and Tumor-Associated Macrophages, and the Soluble Form in the Blood
por: Krijgsman, Daniëlle, et al.
Publicado: (2020)

Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile
por: Krijgsman, Daniëlle, et al.
Publicado: (2019)

The Role of Natural Killer T Cells in Cancer—A Phenotypical and Functional Approach
por: Krijgsman, Daniëlle, et al.
Publicado: (2018)

Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylation
por: Ørskov, Andreas D., et al.
Publicado: (2015)

The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and Treatment
por: de Vries, Natasja L., et al.
Publicado: (2016)

Revising the Role of Integrin Subunit β4 Expression in Colon Cancer Progression and Survival
por: Rademaker, Eva, et al.
Publicado: (2022)

HLA-G: A New Immune Checkpoint in Cancer?
por: Krijgsman, Daniëlle, et al.
Publicado: (2020)

Differential role of HLA-A and HLA-B, C expression levels as prognostic markers in colon and rectal cancer
por: Michelakos, Theodoros, et al.
Publicado: (2022)

Tumor LINE-1 Methylation Level in Association with Survival of Patients with Stage II Colon Cancer
por: Swets, Marloes, et al.
Publicado: (2016)

Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer
por: Zunder, Stéphanie M., et al.
Publicado: (2018)

A Critical Assessment of the Association between HLA-G Expression by Carcinomas and Clinical Outcome
por: van de Water, Ricky B., et al.
Publicado: (2021)

Adjuvant therapy for resected high-risk colon cancer: Current standards and controversies
por: Gill, Sharlene
Publicado: (2014)

Detection of Tumor Cells in Bone Marrow, Peripheral Blood and Lymph Nodes by Automated Imaging Devices
por: Mesker, Wilma E., et al.
Publicado: (2006)

Differences between colon and rectal cancer in complications, short-term survival and recurrences
por: van der Sijp, Max P.L., et al.
Publicado: (2016)

The Molecular and Functional Characteristics of HLA-G and the Interaction with Its Receptors: Where to Intervene for Cancer Immunotherapy?
por: Attia, Jiji V. D., et al.
Publicado: (2020)

Biopsychosocial and clinical characteristics in patients with resected breast and colon cancer at the beginning and end of adjuvant treatment
por: García-García, Teresa, et al.
Publicado: (2019)

Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs
por: Hao, Zhonglin, et al.
Publicado: (2022)

Differences in organization of care are associated with mortality, severe complication and failure to rescue in emergency colon cancer surgery
por: Huijts, Daniëlle D, et al.
Publicado: (2021)

The intra-tumoural stroma in patients with breast cancer increases with age
por: Vangangelt, Kiki M. H., et al.
Publicado: (2019)

Regarding “Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs”
por: Su, I-Hsuan, et al.
Publicado: (2023)

Correlation of Immunological and Histopathological Features with Gene Expression-Based Classifiers in Colon Cancer Patients
por: van de Weerd, Simone, et al.
Publicado: (2022)

Randomized Phase III Study to Assess Efficacy and Safety of Adjuvant CAPOX with or without Bevacizumab in Patients after Resection of Colorectal Liver Metastases: HEPATICA study()()
por: Snoeren, Nikol, et al.
Publicado: (2017)

The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis
por: Frouws, Martine A., et al.
Publicado: (2017)

Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma.
por: Scheithauer, W., et al.
Publicado: (1998)

The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients
por: Hsieh, Mei‐Chin, et al.
Publicado: (2016)

Comparative efficacy and tolerability of adjuvant systemic treatments against resectable colon cancer: a network meta-analysis
por: Cheng, Ji, et al.
Publicado: (2020)

The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: a multicentered retrospective analysis
por: Breadner, Daniel, et al.
Publicado: (2022)

Adjuvant therapy in resectable gastric cancer.
por: Bleiberg, H., et al.
Publicado: (1992)

Intratumoural and peripheral blood lymphocyte subsets in patients with metastatic renal cell carcinoma undergoing interleukin-2 based immunotherapy: association to objective response and survival
por: Donskov, F, et al.
Publicado: (2002)

Dexmedetomidine as an Adjuvant in Peripheral Nerve Block
por: Chen, Zheping, et al.
Publicado: (2023)

In Reply: Overall Survival of Resectable Metastatic Colon Cancer Treated With Neoadjuvant Chemotherapy or Adjuvant Chemotherapy in Non-academic Program
por: Hao, Zhonglin, et al.
Publicado: (2023)

Presence of a High Amount of Stroma and Downregulation of SMAD4 Predict for Worse Survival for Stage I–II Colon Cancer Patients
por: Mesker, Wilma E., et al.
Publicado: (2009)

Marginal resection and adjuvant strontium plesiotherapy in the management of feline eyelid malignant peripheral nerve sheath tumours: two cases
por: Berlato, Davide, et al.
Publicado: (2016)

A method for semi-automated image analysis of HLA class I tumour epithelium expression in rectal cancer
por: Krijgsman, Daniëlle, et al.
Publicado: (2019)

Update of Adjuvant Chemotherapy for Resected Gastric Cancer
por: Oh, Sang Cheul
Publicado: (2012)

Resectable Cholangiocarcinoma: Reviewing the Role of Adjuvant Strategies
por: Cidon, E. Una
Publicado: (2016)

Benefit of Adjuvant Chemoradiotherapy in Resected Gallbladder Carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2019)

Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
por: Crook, Christiana J., et al.
Publicado: (2023)

Prognostic value of ABO blood group in patients with surgically resected colon cancer
por: Cao, X, et al.
Publicado: (2014)

The RelA hydrolase domain acts as a molecular switch for (p)ppGpp synthesis
por: Sinha, Anurag Kumar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lq0bgois83885sj1q1404cust8